Chat with us, powered by LiveChat

Urinary Tract Infection Therapeutics Market

Urinary Tract Infection Therapeutics: By Indication (Complicated UTI, Uncomplicated UTI and Other), By Drug Type (Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitro furans and Other) And Region - Global Analysis of Market Size, Share & Trends for 2019-2020 And Forecasts to 2031

Published on: May-2023
Report Code: FG HC 01496
Pages Count: 170-350
Report Format: PDF

1 Executive Summary 
    1.1. Regional Market Share 
    1.2. Business Trends 
    1.3. Global Urinary Tract Infection Therapeutics Market: COVID-19 Outbreak 
    1.4. Regional Trends 
    1.5. Segmentation Snapshot 
2 Research Methodology 
    2.1. Research Objective 
    2.2. Research Approach 
    2.3. Data Sourcing and Methodology 
    2.4. Primary Research 
    2.5. Secondary Research 
           2.5.1.  Paid Sources
           2.5.2.  Public Sources
    2.6. Market Size Estimation and Data Triangulation 
3 Market Characteristics 
    3.1. Market Definition 
    3.2.   Global Urinary Tract Infection Therapeutics Market: COVID-19 Impact 
    3.3. Key Segmentations 
    3.4. Key Developments 
    3.5. Allied Industry Data 
4 Global Urinary Tract Infection Therapeutics Market – Industry Insights 
    4.1. Industry Segmentation 
    4.2. COVID-19 overview on world economy 
    4.3. Industry ecosystem Channel analysis 
    4.4. Innovation & Sustainability 
5 Macroeconomic Indicators 
6 Recent Developments 
7 Market Dynamics
 
    7.1. Introduction 
    7.2. Growth Drivers 
    7.3. Market Opportunities 
    7.4. Market Restraints 
    7.5. Market Trends 
8 Risk Analysis 
9 Market Analysis 

    9.1. Porters Five Forces 
    9.2. PEST Analysis 
           9.2.1. Political
           9.2.2. Economic
           9.2.3. Social
           9.2.4. Technological
10 Global Urinary Tract Infection Therapeutics Market  
    10.1. Overview 
    10.2. Historical Analysis (2016-2020) 
           10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 Global Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    11.1. Overview 
    11.2. Key Findings 
    11.3. Market Segmentation 
           11.3.1. By Indication
                    11.3.1.1. Complicated UTI
                               11.3.1.1.1. By Value (USD Million) 2021-2031F
                               11.3.1.1.2. Market Share (%) 2021-2031F
                               11.3.1.1.3. Y-o-Y Growth (%) 2021-2031F
                    11.3.1.2. Uncomplicated UTI
                               11.3.1.2.1. By Value (USD Million) 2021-2031F
                               11.3.1.2.2. Market Share (%) 2021-2031F
                               11.3.1.2.3. Y-o-Y Growth (%) 2021-2031F  
                    11.3.1.3. Other
                               11.3.1.3.1. By Value (USD Million) 2021-2031F
                               11.3.1.3.2. Market Share (%) 2021-2031F
                               11.3.1.3.3. Y-o-Y Growth (%) 2021-2031F 
           11.3.2. By Drug Type
                    11.3.2.1. Quinolones
                               11.3.2.1.1. By Value (USD Million) 2021-2031F
                               11.3.2.1.2. Market Share (%) 2021-2031F
                               11.3.2.1.3. Y-o-Y Growth (%) 2021-2031F
                    11.3.2.2. Cephalosporin
                               11.3.2.2.1. By Value (USD Million) 2021-2031F
                               11.3.2.2.2. Market Share (%) 2021-2031F
                               11.3.2.2.3. Y-o-Y Growth (%) 2021-2031F 
                    11.3.2.3. Azoles and Amphotericin B
                               11.3.2.3.1. By Value (USD Million) 2021-2031F
                               11.3.2.3.2. Market Share (%) 2021-2031F
                               11.3.2.3.3. Y-o-Y Growth (%) 2021-2031F 
                    11.3.2.4. Nitro furans
                               11.3.2.4.1. By Value (USD Million) 2021-2031F
                               11.3.2.4.2. Market Share (%) 2021-2031F
                               11.3.2.4.3. Y-o-Y Growth (%) 2021-2031F
                    11.3.2.5.  Other
                               11.3.2.5.1. By Value (USD Million) 2021-2031F
                               11.3.2.5.2. Market Share (%) 2021-2031F
                               11.3.2.5.3. Y-o-Y Growth (%) 2021-2031F
12 North America Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    12.1. Overview 
    12.2. Key Findings 
    12.3. Market Segmentation 
           12.3.1. By Indication
           12.3.2. By Drug Type
    12.4. Country 
           12.4.1. United States
           12.4.2. Canada
13 Europe Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    13.1. Overview 
    13.2. Key Findings 
    13.3. Market Segmentation 
           13.3.1. Indication
           13.3.2. By Drug Type
    13.4. Country 
           13.4.1. Germany
           13.4.2. United Kingdom
           13.4.3. France
           13.4.4. Italy
           13.4.5. Spain
           13.4.6. Russia
           13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 Asia Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    14.1. Overview 
    14.2. Key Findings 
    14.3. Market Segmentation 
           14.3.1. By Indication
           14.3.2. By Drug Type
    14.4. Country 
           14.4.1. India
           14.4.2. China
           14.4.3. South Korea
           14.4.4. Japan
           14.4.5. Rest of APAC
15 Middle East and Africa Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    15.1. Overview 
    15.2. Key Findings 
    15.3. Market Segmentation 
           15.3.1. By Indication
           15.3.2. By Drug Type
    15.4. Country 
           15.4.1. Israel
           15.4.2. GCC
           15.4.3. North Africa
           15.4.4. South Africa
           15.4.5. Rest of Middle East and Africa
16 Latin America Urinary Tract Infection Therapeutics Market Size & Forecast 2021A-2031F 
    16.1. Overview 
    16.2. Key Findings 
    16.3. Market Segmentation 
           16.3.1. By Indication
           16.3.2. By Drug Type
    16.4. Country 
           16.4.1. Mexico
           16.4.2. Brazil
           16.4.3. Rest of Latin America
17 Competitive Landscape 
    17.1. Company market share, 2021 
    17.2. Key player overview 
    17.3. Key stakeholders 
18 Company Profiles 
    18.1. Allergan 
           18.1.1. Company Overview
           18.1.2. Financial Overview
           18.1.3. Key Product; Analysis
           18.1.4. Company Assessment
                    18.1.4.1. Product Portfolio
                    18.1.4.2. Key Clients
                    18.1.4.3. Market Share
                    18.1.4.4. Recent News & Development (Last 3 Yrs.)
                    18.1.4.5. Executive Team
    18.2. Bayer AG 
    18.3. Pfizer, Inc. 
    18.4. GlaxoSmithKline plc 
    18.5. Bristol-Myers Squibb Company 
    18.6. Janssen Global Services, LLC 
    18.7. Lupin Ltd. 
    18.8. Merck & Co., Inc 
    18.9. Almirall, S.A 
    18.10. Other Prominent Players 
19 Appendix 
20 Consultant Recommendation 

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type Select License Type

$3199

Report accessible by 1 user only

Clients